Senior insider sale
GENERATE BIOMEDICINES, INC. — senior position signals high conviction
$536.6K
33.21K shares
What this filing means
ARNOLD FRANCES plans to sell 33.21K shares of GENERATE BIOMEDICINES, INC. valued at approximately $536.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/2/2026ACC: 0001959173-26-006666
Director
Since Feb 2026
33.21K
Shares to sell
$536.6K
Approx. market value
32.21K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
9/23/2020
32.21KTotal acquired32.21K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/23/2020 | Restricted Stock Vesting Compensation | 32.21K | — |
| Total | 32.21K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1K
Market value
$16.0K
9/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
32.21K
Market value
$520.6K
9/2/2026
Total
Units
33.21K
Value
$536.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/1/2026 | 1K | $16.0K | — | Completed |
| Planned — Approximate Date | ||||
9/2/2026 | 32.21K | $520.6K | NASDAQ | Planned |
| Total | 33.21K | $536.6K | ||